MetaCap

Immunocore (IMCR) News

NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

26.41-0.22 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IMCR news summary

We found 7 recent headlines mentioning Immunocore (IMCR): 0 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, IMCR is down 0.83% at $26.41. The most recent story, "Immunocore to present at upcoming investor conferences", was published by GlobeNewswire on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Immunocore headlines

Stocks mentioned alongside IMCR

Compare IMCR